Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schell

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Annals of Hematology|December 15, 2010
Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survivalBart Barlogie, Vanessa Bolejack, Michael Schell, et al.
Frontiers in Genetics|March 26, 2015
Regulation of the DNA damage response by ubiquitin conjugationKerstin Brinkmann, Michael Schell, Thorsten Hoppe, et al.
Nature Structural & Molecular Biology|November 5, 2016
E4 ligase-specific ubiquitination hubs coordinate DNA double-strand-break repair and apoptosisLeena Ackermann, Michael Schell, Wojciech Pokrzywa, et al.
Journal of Applied Clinical Medical Physics|July 26, 2016
A report from the AAPM Subcommittee on Guidelines for Competency Evaluation for Clinical Medical Physicists in Radiation OncologyDaniel C Pavord, Steven Birnbaum, Douglas Bocuzzi, et al.
Oncotarget|April 21, 2017
Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approachAndrew Leone, Gregory Diorio, Wade Sexton, et al.
Optics Letters|August 2, 2019
Gate-tunable optical filter based on conducting oxide metasurface heterostructureJinqiannan Zhang, Jingyi Yang, Michael Schell, et al.
Oncotarget|November 28, 2018
Clinical associations of mucin 1 in human lung cancer and precancerous lesionsAndreas Saltos, Farah Khalil, Michelle Smith, et al.
Cancers|February 25, 2023
Challenges to Recruiting Men on Active Surveillance for Prostate Cancer in Clinical Chemoprevention TrialsNagi B Kumar, Saira Bahl, Jasreman Dhillon, et al.
Journal of Clinical Trials|June 24, 2015
Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung CancerNagi B Kumar, Gwendolyn P Quinn, Mark G Alexandrow, et al.
Cancer Research|January 21, 2015
β-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transitionSmitha Pillai, Jose Trevino, Bhupendra Rawal, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Annals of Hematology|December 15, 2010
Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survivalBart Barlogie, Vanessa Bolejack, Michael Schell, et al.
Frontiers in Genetics|March 26, 2015
Regulation of the DNA damage response by ubiquitin conjugationKerstin Brinkmann, Michael Schell, Thorsten Hoppe, et al.
Nature Structural & Molecular Biology|November 5, 2016
E4 ligase-specific ubiquitination hubs coordinate DNA double-strand-break repair and apoptosisLeena Ackermann, Michael Schell, Wojciech Pokrzywa, et al.
Journal of Applied Clinical Medical Physics|July 26, 2016
A report from the AAPM Subcommittee on Guidelines for Competency Evaluation for Clinical Medical Physicists in Radiation OncologyDaniel C Pavord, Steven Birnbaum, Douglas Bocuzzi, et al.
Oncotarget|April 21, 2017
Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approachAndrew Leone, Gregory Diorio, Wade Sexton, et al.
Optics Letters|August 2, 2019
Gate-tunable optical filter based on conducting oxide metasurface heterostructureJinqiannan Zhang, Jingyi Yang, Michael Schell, et al.
Oncotarget|November 28, 2018
Clinical associations of mucin 1 in human lung cancer and precancerous lesionsAndreas Saltos, Farah Khalil, Michelle Smith, et al.
Cancers|February 25, 2023
Challenges to Recruiting Men on Active Surveillance for Prostate Cancer in Clinical Chemoprevention TrialsNagi B Kumar, Saira Bahl, Jasreman Dhillon, et al.
Journal of Clinical Trials|June 24, 2015
Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung CancerNagi B Kumar, Gwendolyn P Quinn, Mark G Alexandrow, et al.
Cancer Research|January 21, 2015
β-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transitionSmitha Pillai, Jose Trevino, Bhupendra Rawal, et al.
Pageof 3